Roche’s tiragolumab flops in another Phase III lung cancer trial – Pharmaceutical Technology
Shares in Roche opened 0.55% lower at market open following the news. Image credit: Shutterstock / Marlon Trottmann. Roche’s struggles with finding a foothold for